跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOXIFLOXACIN INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MOXIFLOXACIN INJECTION
Authorized
STANDARD
MOXIFLOXACIN INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9060bdad1eb36285
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
9060bdad1eb36285
Drug Approval Canada Name
MOXIFLOXACIN INJECTION
Product Name
MOXIFLOXACIN INJECTION
Status
Marketed
Status Date
2017-08-16
Original Market Date
2017-08-16
Din
02433087
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
52:04.04
Atc Original
J01MA14 MOXIFLOXACIN
Atc Name
j 01 ma 14
Aig Number
0142242002
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)
400 MG / 250 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9060bdad1eb36285
Type
Standard
Back to Health Canada Approvals